Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 LIN28B: an orchestrator of oncogenic signaling in neuroblastoma.

× No keyword cloud information.

7 in total

1. Targeting MYCN in neuroblastoma by BET bromodomain inhibition.

Authors: Alexandre Puissant; Stacey M Frumm; Gabriela Alexe; Christopher F Bassil; Jun Qi; Yvan H Chanthery; Erin A Nekritz; Rhamy Zeid; William Clay Gustafson; Patricia Greninger; Matthew J Garnett; Ultan McDermott; Cyril H Benes; Andrew L Kung; William A Weiss; James E Bradner; Kimberly Stegmaier
Journal: Cancer Discov Date: 2013-02-21 Impact factor: 39.397

2. A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis.

Authors: Robert W Schnepp; Priya Khurana; Edward F Attiyeh; Pichai Raman; Sara E Chodosh; Derek A Oldridge; Maria E Gagliardi; Karina L Conkrite; Shahab Asgharzadeh; Robert C Seeger; Blair B Madison; Anil K Rustgi; John M Maris; Sharon J Diskin
Journal: Cancer Cell Date: 2015-10-17 Impact factor: 31.743

3. Selective impairment of a subset of Ran-GTP-binding domains of ran-binding protein 2 (Ranbp2) suffices to recapitulate the degeneration of the retinal pigment epithelium (RPE) triggered by Ranbp2 ablation.

Authors: Hemangi Patil; Arjun Saha; Eugene Senda; Kyoung-in Cho; MdEmdadul Haque; Minzhong Yu; Sunny Qiu; Dosuk Yoon; Ying Hao; Neal S Peachey; Paulo A Ferreira
Journal: J Biol Chem Date: 2014-09-03 Impact factor: 5.157

4. LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.

Authors: Jan J Molenaar; Raquel Domingo-Fernández; Marli E Ebus; Sven Lindner; Jan Koster; Ksenija Drabek; Pieter Mestdagh; Peter van Sluis; Linda J Valentijn; Johan van Nes; Marloes Broekmans; Franciska Haneveld; Richard Volckmann; Isabella Bray; Lukas Heukamp; Annika Sprüssel; Theresa Thor; Kristina Kieckbusch; Ludger Klein-Hitpass; Matthias Fischer; Jo Vandesompele; Alexander Schramm; Max M van Noesel; Luigi Varesio; Frank Speleman; Angelika Eggert; Raymond L Stallings; Huib N Caron; Rogier Versteeg; Johannes H Schulte
Journal: Nat Genet Date: 2012-10-07 Impact factor: 38.330

5. Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study.

Authors: Yael P Mossé; Emily Lipsitz; Elizabeth Fox; David T Teachey; John M Maris; Brenda Weigel; Peter C Adamson; Mark A Ingle; Charlotte H Ahern; Susan M Blaney
Journal: Clin Cancer Res Date: 2012-09-17 Impact factor: 12.531

6. Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma.

Authors: Tobias Otto; Sebastian Horn; Markus Brockmann; Ursula Eilers; Lars Schüttrumpf; Nikita Popov; Anna Marie Kenney; Johannes H Schulte; Roderick Beijersbergen; Holger Christiansen; Bernd Berwanger; Martin Eilers
Journal: Cancer Cell Date: 2009-01-06 Impact factor: 31.743

7. Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma.

Authors: Sharon J Diskin; Mario Capasso; Robert W Schnepp; Kristina A Cole; Edward F Attiyeh; Cuiping Hou; Maura Diamond; Erica L Carpenter; Cynthia Winter; Hanna Lee; Jayanti Jagannathan; Valeria Latorre; Achille Iolascon; Hakon Hakonarson; Marcella Devoto; John M Maris
Journal: Nat Genet Date: 2012-09-02 Impact factor: 38.330

7 in total

5 in total

Review 1. Bivalent Epigenetic Control of Oncofetal Gene Expression in Cancer.

Authors: Sayyed K Zaidi; Seth E Frietze; Jonathan A Gordon; Jessica L Heath; Terri Messier; Deli Hong; Joseph R Boyd; Mingu Kang; Anthony N Imbalzano; Jane B Lian; Janet L Stein; Gary S Stein
Journal: Mol Cell Biol Date: 2017-11-13 Impact factor: 4.272

LIN28B: an orchestrator of oncogenic signaling in neuroblastoma.

1. Targeting MYCN in neuroblastoma by BET bromodomain inhibition.

2. A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis.

3. Selective impairment of a subset of Ran-GTP-binding domains of ran-binding protein 2 (Ranbp2) suffices to recapitulate the degeneration of the retinal pigment epithelium (RPE) triggered by Ranbp2 ablation.

4. LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.

5. Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study.

6. Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma.

7. Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma.

Review 1. Bivalent Epigenetic Control of Oncofetal Gene Expression in Cancer.

Review 2. Genetic susceptibility to neuroblastoma: current knowledge and future directions.

3. Development of a radiosensitivity gene signature for patients with soft tissue sarcoma.

4. RNA Binding Protein LIN28B: a prime time player shaping neuroblastoma aggression and metastasis.

Review 5. Molecular Genetics in Neuroblastoma Prognosis.